Evaluation of a new interferon-gamma release assay and comparison to tuberculin skin test during a tuberculosis outbreak

International Journal of Infectious Diseases

Volumn 16, Issue 7, 2012, Pages

  Song, Qisheng ^a,b   Guo, Huishan ^c   Zhong, Hui ^c   Liu, Zuoguang ^b   Chen, Xiuqin ^b   Wang, Cui ^d   Touzjian, Neal ^e   Lv, Yichen ^c   Lu, Xiwei ^b   Wang, Qi ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Dalian Tuberculosis Hospital   (China)

^c Haikou VTI Biological Institute   (China)

^d Center for Disease Control of Liaoning Province   (China)

^e Vaccine Technology Incorporated   (United States)

Author keywords

Anti tuberculosis preventive treatment; Level of exposure; Tuberculosis incidence

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; ISONIAZID;

ADULT; ARTICLE; BCG VACCINATION; CHINA; CONTROLLED STUDY; COUGHING; EPIDEMIC; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; SCREENING; TREATMENT DURATION; TUBERCULIN TEST;

ADULT; CHINA; DISEASE OUTBREAKS; FEMALE; HUMANS; INCIDENCE; INTERFERON-GAMMA RELEASE TESTS; MALE; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 84862539025     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.03.003     Document Type: Article

References (22)

1. Mazurek G.H., Jereb J., Vernon A., LoBue P., Goldberg S., Castro K., et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010, 59:1-25.
2. Von Reyn C.F., Horsburgh C.R., Olivier K.N., Barnes P.F., Waddell R., Warren C., et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001, 5:1122-1128.
3. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000;161:S221-47.
4. Sepulveda R.L., Burr C., Ferrer X., Sorensen R.U. Booster effect of tuberculin testing in healthy 6-year-old school children vaccinated with bacillus Calmette-Guérin at birth in Santiago, Chile. Pediatr Infect Dis J 1988, 7:578-581.
5. Hoft D.F., Tennant J.M. Persistence and boosting of bacille Calmette-Guérin-induced delayed-type hypersensitivity. Ann Intern Med 1999, 131:32-36.
6. Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., Stover C.K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996, 178:1274-1282.
7. Brusasca P.N., Colangeli R., Lyashchenko K.P., Zhao X., Vogelstein M., Spencer J.S., et al. Immunological characterization of antigens encoded by the RD1 region of the Mycobacterium tuberculosis genome. Scand J Immunol 2001, 54:448-452.
8. Hill P.C., Fox A., Jeffries D.J., Jackson-Sillah D., Lugos M.D., Owiafe P.K., et al. Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis 2005, 40:273-278.
9. Kang Y.A., Lee H.W., Yoon H.I., Cho B., Han S.K., Shim Y.S., et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005, 293:2756-2761.
10. Cao H., Agrawal D., Kushner N., Touzjian N., Essex M., Lu Y. Delivery of exogenous protein antigens to major histocompatibility complex class I pathway in cytosol. J Infect Dis 2002, 185:244-251.
11. McEvers K., Elrefaei M., Norris P., Deeks S., Martin J., Lu Y., et al. Modified anthrax fusion proteins deliver HIV antigens through MHC class I and II pathways. Vaccine 2005, 23:4128-4135.
12. Holden M., Dubin M.R., Diamond P.H. Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med 1971, 285:1506-1509.
13. Rooney J.J., Crocco J.A., Kramer S., Lyons H.A. Further observations on tuberculin reactions in active tuberculosis. Am J Med 1976, 60:517-522.
14. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999, 159:15-21.
15. Ferrara G., Losi M., D'Amico R., Roversi P., Piro R., Meacci M., et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006, 367:1328-1334.
16. Mahomed H., Hughes E.J., Hawkridge T., Minnies D., Simon E., Little F., et al. Comparison of Mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis 2006, 10:310-316.
17. Arend S.M., Thijsen S.F., Leyten E.M., Bouwman J.J., Franken W.P., Koster B.F., et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007, 175:618-627.
18. Hill P.C., Brookes R.H., Adetifa I.M., Fox A., Jackson-Sillah D., Lugos M.D., et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics 2006, 117:1542-1548.
19. Richeldi L., Ewer K., Losi M., Bergamini B.M., Roversi P., Deeks J., et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med 2004, 170:288-295.
20. Hill P.C., Brookes R.H., Fox A., Fielding K., Jeffries D.J., Jackson-Sillah D., et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 2004, 38:966-973.
21. Pathan A.A., Wilkinson K.A., Klenerman P., McShane H., Davidson R.N., Pasvol G., et al. Direct ex vivo analysis of antigen-specific IFN-γ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001, 167:5217-5225.
22. Zhou Q., Chen Y.Q., Qin S.M., Tao X.N., Xin J.B., Shi H.Z. Diagnostic accuracy of T-cell interferon-gamma release assays in tuberculous pleurisy: a meta-analysis. Respirology 2011, 16:473-480.